Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Lymphoblastic Leukemia
Study results from University of California, Department of Hematology-Oncology broaden understanding of acute lymphoblastic leukemia in children
March 2nd, 2008
A report, 'Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray,' is newly published data in Blood. According to a study from the United States, "Pediatric acute lymphoblastic leukemia (ALL) is a malignant disease resulting from accumulation of genetic alterations. A robust technology, single nucleotide polymorphism oligonucleotide genomic microarray (SNP-chip) in concert with bioinformatics offers the opportunity to discover the genetic lesions associated with ALL." "We examined 399 pediatric ALL samples and their matched remission marrows at 50,000/250,000 SNP...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-02)
|
